Six weeks after the launch of miR Scientific’s liquid biopsy prostate cancer test, the medtech company is running a new campaign to literally shine a light on the disease. Through its so-called ...

Scientists have reported results from an early-stage trial of an immunotherapy drug called VIR-5500. The drug offers new hope for men with advanced prostate cancer who have stopped responding to other ...

A new research paper was published in Genes & Cancer on May 16, 2024, entitled, "Inhibitory effect of miR-377 on the proliferative and invasive behaviors of prostate cancer cells through the ...

Prostate cancer remains one of the most common cancers among men, yet current screening tools often fail to distinguish between harmless and aggressive forms of the disease. This review highlights how ...

Your prostate is an organ that makes some of the fluid that’s part of semen. It’s below your bladder and in front of your rectum. Prostate cancer happens when the cells in your prostate gland grow out ...

Prostate cancer is the most common type of cancer in men. More than 1 in 10 men will get it at some point in their life. Your chances of getting prostate cancer will depend on many different things: ...

In a study published in the journal Genes & Diseases, researchers from Army Medical University and Shenzhen University investigated the pivotal role of miR-18a-5p, a microRNA, in the development and ...

Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Newsflash for the kings, queens, and anyone with a penis who hasn't figured it out. The real male ...

The latest treatments for an enlarged prostate may help reduce prostate size or reduce symptoms. Treatments include water vapor thermal therapy, prostatic urethral lift, and prostate artery ...